Unlisted pharmas receive excellent sales report card
Unlisted pharmaceutical companies, most of them are relying on selling generic products, were observed to receive an excellent report card for their business last year.
Their sales were increased by more than 10% and had profitability with fairly decent operating profits, but the gap between the...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
